Nanodelivery strategies for the treatment of multidrug-resistant bacterial infections

Research output: Contribution to journalArticle

241 Downloads (Pure)

Abstract

One of the most important health concerns in society is the development of nosocomial infections caused by multidrug‐resistant pathogens. The purpose of this review is to discuss the issues in current antibiotic therapies and the ongoing progress of developing new strategies for the treatment of ESKAPE pathogen infections, which is acronymized for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. We not only examine the current issues caused by multidrug resistance but we also examine the barrier effects such as biofilm and intracellular localization exploited by these pathogens to avoid antibiotic exposure. Recent innovations in nanomedicine approaches and antibody antibiotic conjugates are reviewed as potential novel approaches for the treatment of bacterial infection, which ultimately may expand the useful life span of current antibiotics.
Original languageEnglish
Pages (from-to)1-11
JournalJournal of Interdisciplinary Nanomedicine
Early online date04 Sep 2018
DOIs
Publication statusEarly online date - 04 Sep 2018

    Fingerprint

Cite this